Approval · Notice of Compliance 22273 · 2019
LIBRAX: Notice of Compliance 22273
Issued June 11, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 22273
- Date
- June 11, 2019
- Company
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Change in product ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LIBRAX | 00115630 | Marketed |
Medicinal ingredients
- CHLORDIAZEPOXIDE HCL 5 MG per CAP
- CLIDINIUM BROMIDE 2.5 MG per CAP